Zacks.com Announces that Dr. Edward Olmstead Highlights an Option for the Following Stock: Morgan Stanley.

CHICAGO -- Dr. Edward Olmstead sees a rather tricky period for trading in the near future. But there's always opportunities to move forward by using options, and this expert has market analysis and an intermediate to long-term option play to keep you on target. Read about an option for Morgan Stanley (NYSE:MWD). Dr. Edward Olmstead is editor of the Options Professor newsletter. Click here for the full story exclusively on Zacks.com: http://at.zacks.com/?id=84

Here are the highlights from the Featured Expert column:

Paradox Street from the monthly edition on October 7

The market has been acting a bit more paradoxically than usual. Transports have been hitting 52-week highs right along with crude oil. Momentum money is eschewing the old high beta standbys, the semiconductors, and jumping on the tranny train. For the most part, Dr. Edward Olmstead and his team had a very successful month with their options picks. Seven out of ten trades initiated in September were winners. Research in Motion (NASDAQ: RIMM) is still open and showing a small profit at this time.

Meanwhile, earnings season starts soon and presents Dr. Olmstead and his team with a particularly tricky period in which to trade. Then, he has some mutual fund end-of-fiscal year buying and selling to contend with later in the month. Currently, it is a little late to get long in the favorite momentum names and a little early to get bearish about anything.

Play of the Month

In every monthly issue, Dr. Olmstead features an intermediate to long-term play. This month he features an intermediate term bearish trade on a big name company in the financial sector.

Morgan Stanley (NYSE: MWD) is a provider of various financial services, including capital-raising, retail brokerage, investment advisory and asset management. On Wednesday (10/6) MWD closed at $49.41. Based upon fundamental and technical analysis, it is projected that over the next 3-4 months, MWD will fall to the level of $46.50.

Trade: Buy 1 Jan(05) 55 put for $6.30 per share.

Cost = $630

Max risk = $630.

Dr. Olmstead's first target is for MWD to fall to $47.50. If that occurs anytime before mid-November, this trade should show a profit of at least $160 for a gain of 25% or better.

Read Dr. Edward Olmstead's complete commentary, along with his next target and exit strategy for the above-mentioned option, by clicking: http://at.zacks.com/?id=85

About Zacks Featured Experts

To be a successful investor you need professional advice. Experts who know what they're talking about and can help you achieve your financial goals in good markets...and especially in bad ones will help you improve your portfolio. That is why Zacks Investment Research has assembled the best investment experts in the business to offer their powerful advisory newsletters to you on all the major investment topics: Stocks, Mutual Funds, Bonds, Options, Futures etc.

Recommendations from Featured Experts Highlighted in FREE Investment Newsletter

The best way to tap into the powerful advice from these experts is through our free weekly e-mail newsletter, "Profit from the Pros". Each week we highlight several Featured Experts in this free e-mail newsletter. Get your free subscription to "Profit from the Pros" at: http://at.zacks.com/?id=86

About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 to compile, analyze, and distribute investment research to both institutional and individual investors. The guiding principle behind our work is the belief that investment experts, such as brokerage analysts and investment newsletter writers, have superior knowledge about how to invest successfully. Our goal is to unlock their profitable insights for our customers. And there is no better way to enjoy this investment success, than with a FREE subscription to "Profit from the Pros" weekly e-mail newsletter. For your free newsletter, visit http://at.zacks.com/?id=87

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.